Predictors of survival in patients with persistent nodal metastases after preoperative chemotherapy for esophageal cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Predictors of survival in patients with persistent nodal metastases after preoperative chemotherapy for esophageal cancer

Published:2010-02 Issue:2 Volume:139 Page:387-394
ISSN:0022-5223
Container-title:The Journal of Thoracic and Cardiovascular Surgery
language:en
Short-container-title:The Journal of Thoracic and Cardiovascular Surgery

Author:

Stiles Brendon M.,Christos Paul,Port Jeffrey L.,Lee Paul C.,Paul Subroto,Saunders James,Altorki Nasser K.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,Surgery

Reference21 articles.

1. Australasian Gastro-Intestinal Trials Group. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis;Gebski;Lancet Oncol,2007

2. Concurrent radiation therapy and chemotherapy followed by esophagectomy for localized esophageal carcinoma;Bates;J Clin Oncol,1996

3. Combined preoperative chemotherapy and radiotherapy in patients with locally advanced esophageal cancer. Interim analysis of a phase II trial;Stahl;J Clin Oncol,1996

4. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma;Urba;J Clin Oncol,2001

5. Preoperative radiation and chemotherapy for localized squamous cell carcinoma of the esophagus: a RTOG Study;Seydel;Int J Radiat Oncol Biol Phys,1988

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adjuvant therapy provides no additional recurrence-free benefit for esophageal squamous cell carcinoma patients after neoadjuvant chemoimmunotherapy and surgery: a multi-center propensity score match study;Frontiers in Immunology;2024-02-05

2. ASO Perspectives: Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer: Never Stop Questioning;Annals of Surgical Oncology;2022-02-19

3. Survival risk prediction model for patients with pT1–3 N0M0 esophageal squamous cell carcinoma after R0 esophagectomy with two-field lymphadenectomy for therapeutic purposes;Journal of Cardiothoracic Surgery;2021-05-01

4. A Phase II Study Demonstrates No Feasibility of Adjuvant Treatment with Six Cycles of S-1 and Oxaliplatin in Resectable Esophageal Adenocarcinoma, with ERCC1 as Biomarker for Response to SOX;Cancers;2021-02-17

5. Adjuvant Therapy for Node-Positive Esophageal Cancer After Induction and Surgery: A Multisite Study;The Annals of Thoracic Surgery;2019-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3